Loading clinical trials...
Loading clinical trials...
The objective of this survey is to determine the safety and efficacy of the ClotTriever Thrombectomy System under daily clinical practice after marketing approval in Japan. This device was designated as a subject of use results evaluation at the time of application for manufacturing and marketing approval.
Age
All ages
Sex
ALL
Healthy Volunteers
No
Chiba University Hospital
Chuo, Chiba, Japan
Ota Memorial Hospital
Ōta, Gunma, Japan
St. Marianna University Hospital
Kawasaki, Kanagawa, Japan
National Cerebral and Cardiovascular Center
Suita, Osaka, Japan
Asahikawa Medical Hospital
Asahikawa, Japan
Asahi General Hospital
Chiba, Japan
Nozaki Tokushukai Hospital
Daitō, Japan
Shonan Kamakura
Kanagawa, Japan
Kyoto Katsura Hospital
Kyoto, Japan
Nara City Hospital
Nara, Japan
Start Date
February 17, 2025
Primary Completion Date
March 1, 2028
Completion Date
December 1, 2028
Last Updated
February 10, 2026
100
ESTIMATED participants
ClotTriever® Thrombectomy System
DEVICE
Lead Sponsor
Inari Medical
Collaborators
NCT07102160
NCT06519435
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06451003